Search results
Results from the WOW.Com Content Network
The cost varies, as with all medication, from country to country, it is about $150/month in the US, and about €60 in Germany. Transdermal testosterone has the advantage of delivering a consistent supply of hormones over a given period and having a simple method of diffusion. [27]
Most insurances covering gender affirming care will over generic and FDA approved hormone replacement therapy. [115] If a clinician recommends a brand name hormone replacement therapy then insurance will conditionally accept it based on recommendation, cost, policy, and healthcare needs. [115]
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
A 2022 review article concluded that DIY hormone replacement therapy "is related to challenges finding knowledgeable and non-stigmatising health workers, lack of access to appropriate services, exclusion, discomfort managing relationships with health workers, cost and desire for a faster transition." [1]
Although gender-affirming surgeries are available, trans people in Peru often face barriers to gender-affirming care (e.g., lack of qualified and willing providers, high cost, restrictive gatekeeping in assessment for hormones and surgery), and trans individuals may face malpractice and various forms discrimination. [61]
Masculinizing gender-affirming surgery for transgender men or transmasculine non-binary people includes a variety of surgical procedures that alter anatomical traits to provide physical traits more comfortable to the trans man's male identity and functioning.
It is estimated that a male-to-female transition can cost between US$7,000 and $24,000; female-to-male transition can exceed US$50,000. [8] The Defense Department's yearly budget for healthcare is $6 billion, the numbers found in the study show the cost to treat service members with GD would fall between $2.4 million and $8.4 million, that is ...
According to pediatric endocrinology expert Brad Miller, pharmaceutical companies that make puberty blocker drugs for children with gender dysphoria have refused to submit them for FDA approval because doing so would cost too much money and "because (transgender treatment) was a political hot potato." [59]